ArticleCureus2026
Definitive Interstitial Brachytherapy for Isolated Cutaneous Metastasis in Breast Cancer.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous metastasis as the sole site of recurrence in breast cancer is rare and poses a unique therapeutic challenge due to limited consensus on optimal management strategies. We present the case of a 40-year-old female with isolated cutaneous metastasis over the left side of the neck from previously treated breast cancer, presenting 1.5 years after completion of primary therapy. Following evaluation, the patient was treated with interstitial high-dose-rate brachytherapy, followed by maintenance systemic therapy with anastrozole and palbociclib. At six months of follow-up, she achieved a complete clinical response with minimal toxicity. This case highlights the potential role of interstitial brachytherapy as an effective, organ-preserving treatment modality in selected patients with isolated cutaneous metastasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.